When:      Wednesday, April 25th, 2018, 6:00-8:30 PM
Where:      Porterhouse Restaurant
60 E. Third Ave
San Mateo, CA
Pricing:    $20, Early Bird Registration by 5:00pm, Friday April 20
$25, Pre-Registration by midnight, Tuesday April 24
$30 walk-in (cash only)
Register:  https://bpc2018aprevent.eventzilla.net/

SPRING is HERE and BPC is BACK!

At the close of Q1’18, what is on YOUR horizon for the rest of this year? If 2017 M&A closed with $200B in deals, how is 2018 stacking up? 2017 saw 46 new drugs approved, the most since 1996. What is driving 2018 approvals and how is 21st Century Cures playing out?

JP Morgan 2018 saw an impressive volume of companies representing the Chinese delegation. What are their targets, who’s winning, who’s losing and how does deal making with Chinese companies differ from deals in the US and Europe?

Finally: what’s the Big Data? How is in silico data revolutionizing drug discovery and while there are real advantages, what are the weaknesses? Is the intersection of digital health technology and biopharma creating the biggest paradigm shift in the history of modern healthcare: the patient as the ultimate customer? Who in biotech and pharma is leading or lagging?

If it’s a hot topic in biotech, we’re talking about it at BPC and what we talk about could be featured in our next leading edge event! Come join us for drinks and happy hour eats, meet new industry professionals and catch up with old colleagues!

Cheers!

The BPC Board